Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Jan 31 2025

· Issued by Oxygenta Pharmaceutical Limited

Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company").

View Attachment